Thomas Pile, PharmD, CDCES

home / authors / thomas-pile-pharmd-cdces

Articles

Pharmacist counting pills -- Image credit: sutlafk | stock.adobe.com

Securing the Supply Chain: The DSCSA and the New Importation Policy in Florida

Craig Kimble, PharmD, MBA, MS, BCACP;Thomas Pile, PharmD, CDCES
March 19th 2024

In January 2024, Florida became the only state to allow the importation of medications for public use.

Read More

Health care worker wearing PPE

Strategies to Help Eliminate Drug Exposure Risks in the Workplace

Thomas Pile, PharmD, CDCES;Craig Kimble, PharmD, MBA, MS, BCACP;Alberto Coustasse, DrPH, MD, MBA, MPH
November 14th 2023

Safe handling of hazardous drugs plays a vital role in patient care.

Read More

Credit: tyyang - stock.adobe.com

Navigating the Path to Safe Compounding in Health Systems

Thomas Pile, PharmD, CDCES;Craig Kimble, PharmD, MBA, MS, BCACP;Alberto Coustasse-Hencke, DrPH, MD, MBA, MPH
July 14th 2023

Drug shortages have led to increased use of compounding pharmacy.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD